Drug license and management rules revised

The Korea Food and Drug Administration says it has recently revised drug license and management rules.

Under the revised rules, it will be possible for a drug manufacturer to change the manufacturing site of active ingredient(s) in the drug license, if it is proven through a comparative dissolution testing between medicinal products.

The KFDA said the assignment of a drug license may be a...